1-3 of 3
Ronan Garlantezec
Close
Sort by
Journal Articles

What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort

Aurore Perrot, Olivier Decaux, Bruno Royer, Denis Caillot, Karim Belhadj Merzoug, Agathe Farge, Laurent Frenzel, Cécile Sonntag, Bohrane Slama, Emmanuelle Bourgeois-Petit, Philippe Moreau, Laurent Voillat, Odile Luycx, Lotfi Benboubker, Gian-Matteo Pica, Frederic Maloisel, Jean-Richard Eveillard, Caroline Algrin, Anna Schmitt, Ronan Garlantézec, Nathalie Texier, Raphael Germain, Marion Willaime, Cyrille Hulin
Journal: Blood
Blood (2022) 140 (Supplement 1): 4379–4381.
https://doi.org/10.1182/blood-2022-158484
Published: 2022
Journal Articles

Real-Life Survival Data after Triple-Exposure to Proteasome Inhibitors (PI), Immunomodulators (IMID) and Anti-CD38 in Multiple Myeloma Patients in the Emmy Cohort

Aurore Perrot, Cyrille Hulin, Margaret Macro, Laurent Frenzel, Carla Araujo, Philippe Moreau, Bruno Royer, Karim Belhadj, Denis Caillot, Xavier Leleu, Anne Vekhoff, Samantha Schulmann, Salomon Manier, Lionel Karlin, Laure Vincent, Sophie Rigaudeau, Driss Chaoui, Ronan Garlantezec, Nathalie Texier, Marion Willaime, Catherine Boccaccio, Olivier Decaux
Journal: Blood
Blood (2021) 138 (Supplement 1): 3764.
https://doi.org/10.1182/blood-2021-149433
Published: 2021
Journal Articles

RD Vs. VRD: What Is the First-Line, Real-Life Management of Multiple Myeloma Patients Ineligible for Stem Cell Auto Transplantation in the Emmy Cohort?

Olivier Decaux, Aurore Perrot, Laurent Frenzel, Bruno Royer, Carla Araujo, Karim Belhadj, Philippe Moreau, Denis Caillot, Xavier Leleu, Agathe Farge, Anne Vekhoff, Samantha Schulmann, Jean Fontan, Frederique Orsini, Laurence Sanhes, Valentine Richez, Arnaud Jaccard, Ronan Garlantezec, Nathalie Texier, Raphael Germain, Catherine Boccaccio, Cyrille Hulin
Journal: Blood
Blood (2021) 138 (Supplement 1): 3766.
https://doi.org/10.1182/blood-2021-149480
Published: 2021